SOME 89% of private healthcare facilities have started displaying medicine prices since the introduction of the Medicine Price Display Initiative in May last year, says the Health Ministry.
It said the initiative was aimed at helping the public compare prices and make more informed purchasing decisions when buying medicines.
“Monitoring conducted between May 2025 and September 2026 involving 5,986 private healthcare facilities and community pharmacies found that 5,332 premises, or 89.1%, had started displaying medicine prices.
“Of that total, 3,905 premises (65.2%) achieved a satisfactory level of display, while 649 premises (10.8%) have yet to display medicine prices,” said the ministry in a written parliamentary reply to Tan Kar Hing (PH-Gopeng).
“By facility category, community pharmacies recorded the highest satisfactory display rate at 73.1%, followed by private hospitals at 61.4%, private medical clinics at 57.2% and dental clinics at 43.6%.”
The ministry noted that the initiative, introduced on May 1, 2025, subsequently faced legal challenges from industry groups when several medical and dental practitioners’ associations filed an application for judicial review in July 2025.
“Following this, on May 21, 2026, the Kuala Lumpur High Court granted a stay on the full enforcement of the order. This decision has implications for the full enforcement of the Medicine Price Display Initiative,” said the ministry.
Despite this, it said it would continue educational, advocacy and monitoring efforts to improve compliance among private healthcare providers.
The ministry noted that the public views the medicine price display as enhancing information transparency, facilitating price comparisons and encouraging healthier competition among healthcare service providers, and noted that this was backed by a survey where 90% of consumers agreed.
Additionally, the ministry said a study was expected to begin at the end of this year in collaboration with the National Institutes of Health and the Pharmacy Services Programme to assess the initiative’s impact on consumer behaviour and identify implementation challenges.
The findings are expected by the end of 2028.
